<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35570712</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1398-9995</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>16</Day>
            </PubDate>
          </JournalIssue>
          <Title>Allergy</Title>
          <ISOAbbreviation>Allergy</ISOAbbreviation>
        </Journal>
        <ArticleTitle>First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/all.15374</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Polymerized allergens conjugated to non-oxidized mannan (PM-allergoids) are novel vaccines targeting dendritic cells (DCs). Previous experimental data indicate that PM-allergoids are readily taken up by DCs and induce Treg cells. This first-in-human study was aimed to evaluate safety and to find the optimal dose of house dust mite PM-allergoid (PM-HDM) administered subcutaneously (SC) or sublingually (SL).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In a randomized, double-blind, double-dummy, placebo-controlled trial, 196 subjects received placebo or PM-HDM at 500, 1,000, 3,000 or 5,000 mannan-conjugated therapeutic units (mTU)/mL in 9-arm groups for 4 months. All subjects received 5 SC doses (0.5 mL each) every 30 days plus 0.2 mL SL daily. The primary efficacy outcome was the improvement of titrated nasal provocation tests (NPT) with D. pteronyssinus at baseline and at the end of the study. All adverse events and reactions were recorded and assessed. Secondary outcomes were the combination of symptom and medication scores (CSMS) and serological markers.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">No moderate or severe adverse reactions were reported. Subjects improving the NPT after treatment ranged from 45% to 62% in active SC, 44% to 61% in active SL and 16% in placebo groups. Statistical differences between placebo and active groups were all significant above 500 mTU, being the highest with 3,000 mTU SL (p=.004) and 5,000 mTU SC (p=.011). CSMS improvement over placebo reached 70% (p&lt;.001) in active 3,000 mTU SC and 40% (p=0.015) in 5,000 mTU SL groups.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PM-HDM immunotherapy was safe and successful in achieving primary and secondary clinical outcomes in SC and SL at either 3,000 or 5,000 mTU/mL.</AbstractText>
          <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nieto</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Pediatric Allergy and Pneumology. Hospital Universitari i Politècnic la Fe, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazón</LastName>
            <ForeName>Ángel</ForeName>
            <Initials>Á</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Pediatric Allergy and Pneumology. Hospital Universitari i Politècnic la Fe, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nieto</LastName>
            <ForeName>María</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Pediatric Allergy and Pneumology. Hospital Universitari i Politècnic la Fe, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ibáñez</LastName>
            <ForeName>Ethel</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Allergy, Hospital Universitari i Politècnic la Fe, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jang</LastName>
            <ForeName>Dah-Tay</ForeName>
            <Initials>DT</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Pediatric Allergy and Pneumology. Hospital Universitari i Politècnic la Fe, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calaforra</LastName>
            <ForeName>Susana</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. Hospital Manises, (Valencia), Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alba</LastName>
            <ForeName>Pilar</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. Hospital Manises, (Valencia), Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pérez-Francés</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. University Hospital Doctor Peset, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Llusar</LastName>
            <ForeName>Ruth</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. University Hospital Doctor Peset, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Montoro</LastName>
            <ForeName>Javier</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. University Hospital Arnau de Vilanova, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mateo</LastName>
            <ForeName>Antonio de</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. University Hospital, Castellón, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alamar</LastName>
            <ForeName>Remedios</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. University Hospital, Castellón, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Qutob</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0003-4837-782X</Identifier>
            <AffiliationInfo>
              <Affiliation>Allergy Service. University Hospital de la Plana, Castellón, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fernández</LastName>
            <ForeName>Javier</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-1065-7199</Identifier>
            <AffiliationInfo>
              <Affiliation>Allergy Service. Hospital General Universitario Dr. Balmis, ISABIAL, Alicante, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moral</LastName>
            <ForeName>Luis</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-7066-6073</Identifier>
            <AffiliationInfo>
              <Affiliation>Pediatric Allergy and Respiratory Unit, Hospital Universitario Dr. Balmis, ISABIAL, Alicante, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Toral</LastName>
            <ForeName>Teresa</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Allergy and Respiratory Unit, Hospital Universitario Dr. Balmis, ISABIAL, Alicante, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antón</LastName>
            <ForeName>Mónica</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. University Hospital Vinalopó, Elche, (Alicante), Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andreu</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. Hospital Vega Baja,Orihuela, (Alicante), Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferrer</LastName>
            <ForeName>Ángel</ForeName>
            <Initials>Á</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service. Hospital Vithas, Alicante, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flores</LastName>
            <ForeName>Isabel-María</ForeName>
            <Initials>IM</Initials>
            <AffiliationInfo>
              <Affiliation>Allergy Service, Elche, Hospital.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cerdá</LastName>
            <ForeName>Neus</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>BioClever, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Del Pozo</LastName>
            <ForeName>Sandra</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Inmunotek, S.L., (Madrid), Alcalá de Henares, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Caballero</LastName>
            <ForeName>Raquel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Inmunotek, S.L., (Madrid), Alcalá de Henares, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Subiza</LastName>
            <ForeName>José Luis</ForeName>
            <Initials>JL</Initials>
            <Identifier Source="ORCID">0000-0002-0134-5321</Identifier>
            <AffiliationInfo>
              <Affiliation>Inmunotek, S.L., (Madrid), Alcalá de Henares, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Casanovas</LastName>
            <ForeName>Miguel</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-2330-3963</Identifier>
            <AffiliationInfo>
              <Affiliation>Inmunotek, S.L., (Madrid), Alcalá de Henares, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Denmark</Country>
        <MedlineTA>Allergy</MedlineTA>
        <NlmUniqueID>7804028</NlmUniqueID>
        <ISSNLinking>0105-4538</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Allergoid</Keyword>
        <Keyword MajorTopicYN="N">Clinical trial</Keyword>
        <Keyword MajorTopicYN="N">House dust mite</Keyword>
        <Keyword MajorTopicYN="N">Immunotherapy</Keyword>
        <Keyword MajorTopicYN="N">Mannan</Keyword>
        <Keyword MajorTopicYN="N">Polymerized</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>3</Hour>
          <Minute>33</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35570712</ArticleId>
        <ArticleId IdType="doi">10.1111/all.15374</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
